New Delhi: India tends to have a large surplus of covid vaccines at the end of December as 15.63 crore doses are expected to be needed in the month for adult populations, while production capacity increases steadily, the official source said.
At least 31 doses of Covid Vaccine Crore (Covishield and Covaxin) tend to be produced in December, almost four times 7.9 crore doses made in May, showing an increase in production.
With higher coverage than the first dose and the scheduled administration of the second dose after the specified gap, the local needs of the Jabs have decreased sharply in November.
About 10.4 doses of crore have been provided so far, while 21.64 doses are not used by crorses available with America and UTS on Monday morning.
The government plans to maximize the use of shares available at the end of this month to aim for the first 100% dose range and Jab for those who are due for second shot after the specified interval, the official said.
There will be several inventories from this month (November).
We hope to provide a total of 22 crore doses in November, “said an official.
A total of 28 doses of Crore (Covishield and Covaxin) were produced during this month until November 19.
From this, Covishield contributed 22.3 crores, while the remaining 5, 6 Crore is from Covaxin.
While the center supplies 15.8 doses of crore to States and the United States, the private sector only has around 36,200 doses during the month, official data until November 19 shows.
While around 30 doses of crore are expected to be obtained by The government by the end of this month, some of which will also go to exports.
A total of around 117.6 crore doses have been given until Monday 9 nights.
While around 82% of adult populations have received at least the first dose, almost 43% are now fully vaccinated with vaccine doses .
In a letter sent to the country and UTS on Monday, Health Secretary Rajesh Bhushan said, “the district must be Identify all the remaining beneficiaries and mobilize them to vaccinate based on priorities.
“Suggest innovative strategies to encourage those who have to be vaccinated, he said local ambassadors can be involved and ordered to expand coverage.
India is likely to take advantage of only half of the vaccine produced in December
